Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X).

J, Rosenstock; D, Raccah; L, Korányi; L, Maffei; G, Boka; P, Miossec; JE, Gerich

doi:10.2337/dc12-2709

Public

Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X).

Shared by NobleBlocks on May 22, 2013 • 12:00 AM UTC

Authors:

Rosenstock J

Raccah D

Korányi L

Abstract

<h4>Objective</h4>To compare efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled with metformin.<h4>Research design and methods</h4>Adults with diabetes inadequately controlled (HbA1c 7-10%) with metformin were randomized to lixisena...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!